Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study-Reference-Cited by-同舟云学术

Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study

Published:2022-03-17 Issue:4 Volume:42 Page:345-354
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Ruggeri Matteo^ORCID,Signorini Alessandro,Caravaggio Silvia,Rua João,Luís Nuno,Braz Sandra,Aragão Filipa

Funder

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-022-01128-8.pdf

Reference32 articles.

1. OECD/European Union. Health at a Glance: Europe 2020: State of Health in the EU Cycle. OECD Publishing, Paris, France. 2020. p. 53. https://www.oecd.org/health/health-at-a-glance-europe/. Accessed 23 Apr 2021.

2. Milhinhos A, Costa PM. On the progression of COVID-19 in Portugal: a comparative analysis of active cases using non-linear regression. Front Public Health. 2020;8:495. https://doi.org/10.3389/fpubh.2020.00495.

3. Ritchie H, Ortiz-Ospina E, Beltekian D, Mathieu E, Hasell J, Macdonald B, Giattino C, Appel C, Rodés-Guirao L, Roser M. Coronavirus Pandemic (COVID-19)—the Data. Our World in Data. 2021. https://ourworldindata.org/coronavirus. Accessed 9 Mar 2022.

4. República Portuguesa, XXII Governo. Declaração de Situação de Alerta até 9 de abril de 2020. República Portuguesa, 2020. https://www.portugal.gov.pt/pt/gc22/comunicacao/comunicado?i=declaracao-de-situacao-de-alerta-ate-9-de-abril-de-2020. Accessed 28 Apr 2021.

5. Worldometer. Portugal Coronavirus Cases. Worldometer. 2021. https://www.worldometers.info/coronavirus/. Accessed 6 Dec 2021.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study;Italian Journal of Medicine;2024-06-03

2. Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review;PharmacoEconomics;2024-05-10

3. Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations;Frontiers in Pharmacology;2023-11-16

4. Casirivimab and imdevimab: Cost-effectiveness analysis of the treatment based on monoclonal antibodies on outpatients with Covid-19;PLOS ONE;2023-02-10

5. Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review;Infection;2022-10-12